In the kidney, treatment with RAP-011 resulted in reduced expression of tissue Act-A and decreased p-SMAD2/3, which were associated with increased renal α-Klotho expression and decreased renal fibrosis and proteinuria. This evidence concerns the gene ACTA1 and renal fibrosis.